| 000 | 00937 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250516052402.0 | ||
| 264 | 0 | _c20111230 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1525-139X | ||
| 024 | 7 |
_a10.1111/j.1525-139X.2011.00911.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCejka, Daniel | |
| 245 | 0 | 0 |
_aShould teriparatide ever be used for adynamic bone disease? _h[electronic resource] |
| 260 |
_bSeminars in dialysis _c |
||
| 300 |
_a431-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aChronic Kidney Disease-Mineral and Bone Disorder _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aTeriparatide _xtherapeutic use |
| 700 | 1 | _aHaas, Martin | |
| 773 | 0 |
_tSeminars in dialysis _gvol. 24 _gno. 4 _gp. 431-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1525-139X.2011.00911.x _zAvailable from publisher's website |
| 999 |
_c21094845 _d21094845 |
||